Group Buy round 4:
The following people have paid for round 4.
I am placing the order and paying the supplier now.
ie: No more round 4 orders can be accepted.
A big thank you to everyone who ...'overpaid'. The extra funds are most welcome and being put aside for a new notebook = my online sanity! Thx!
Name Amount in grams
splib 300
Bryan03 30
Library 60
jack romaine 50
knasse 30 (2nd buy)
khalidnt 15
Nicof83 30
MarcB 100 (2nd buy)
togl 50
rikelme 10 (2nd buy)
mlsirkis 50 (2nd buy)
45rpm 25 (2nd buy)
Mikey 25
Total 775 grams
I note that some people are buying both Nilotinib and Dasatinib.
http://www.longecity...om-nyles/page-3
Most likely for R&D into its senescent cell and old malfunctioning mitochondria killing abilities, as well as its anti fibrotic properties. In short: Anti aging properties.
I have not, as yet, looked for, or come across any literature on the concomitant use of Nilotinib, Dasatinib and Quercetin , CLA etc.
While the effect is quite likely to be additive and quite possibly synergistic, the side effects may well be too..!?
If anyone has found any literature or has any experience in this regard; plz post.
NB that Nilotinib can increase the QT Interval of the heart and can lead to heart failure in people with heart arrhythmias or similar heart issues.
Anyone with any hint of irregular heart rhythms (arrhythmias)/QT interval issues etc needs to be very-very wary of Nilotinib!
The testing of QT Interval and Potassium and Magnesium levels is obligatory in Nilotinib package inserts IIRC. I highly recommend doing so.
Too high levels of Potassium and/or Magnesium is as bad as too low..?
http://www.longecity...ndpost&p=771687
http://www.mayoclini...es/con-20025388
https://en.wikipedia...iki/QT_interval
Disclaimer:
I am not a doctor, nor do I claim to have any formal medical background.
I am not liable, either expressly or in an implied manner, nor claim any responsibility for any physical or emotional problems that may occur directly or indirectly from the use of any supplement or medication, or advice.
Products currently covered by valid patents are offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Section 68B of the Patents Act of 1953 in New Zealand; (vi) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (vii) such similar laws and rules as may apply in various other countries. In the European Union, equivalent exemptions are allowed under the terms of EC Directives 2001/82/EC (as amended by Directive 2004/28/EC) and 2001/83/EC (as amended by Directives 2002/98/EC, 2003/63/EC, 2004/24/EC and 2004/27/EC). Any patent infringement issue and resulting liability is solely at buyer's risk.
Please read the warnings and contraindications etc carefully before beginning any research with Nilotinib or any other concomitant medication or supplement:
https://www.pharma.u...pdf/tasigna.pdf
http://www.fda.gov/S...n/ucm218929.htm
Edited by Logic, 12 December 2016 - 02:40 PM.